Skip to content

Clinical trials

Anemia, Refractory, with Excess of Blasts trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Country / region: Germany Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20091
20101
20111
20131
20141
20151
20191
20201
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated3
Recruiting2
Not yet recruiting2
Unknown status2
Withdrawn1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Traws Pharma, Inc.3
Technische Universität Dresden2
Celgene1
Heinrich-Heine University, Duesseldorf1
Novartis Pharmaceuticals1
Skyline Diagnostics BV1
Taiho Oncology, Inc.1
University Hospital Tuebingen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts16
Myelodysplastic Syndromes12
Leukemia, Myelomonocytic, Chronic6
Leukemia4
Leukemia, Myeloid, Acute4
Anemia, Refractory3
Cytopenia2
Hematologic Diseases2
Anemia1
Congenital Abnormalities1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.